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Background: The burden of dementia is poorly understood in Nigeria. We sought 
to gather available epidemiologic evidence on dementia in Nigeria to provide coun-
try-wide estimates of its prevalence and associated risks.
Methods: We searched MEDLINE, EMBASE, Global Health, Africa Journals Online 
(AJOL) and Google Scholar for epidemiologic studies on dementia in Nigeria from 
1990 to 2018. We pooled crude estimates using random effects meta-analysis. A 
meta-regression epidemiologic model, using the United Nations demographics for 
Nigeria, was used to estimate the absolute number of people living with dementia 
in Nigeria in 1995 and 2015.
Results: Our searches returned 835 studies, of which nine were selected. These in-
cluded 10 820 individuals with a median age of 74.4 years. Heterogeneity (I2=98.8%, 
P<0.001) was high across studies. Five studies were conducted in the South-west, 
and four studies were rated as high quality. The pooled crude prevalence of demen-
tia in Nigeria was 4.9% (95% CI: 3.0-6.9) with prevalence significantly higher in 
women (6.7%, 3.6-9.9) compared to men (3.1%, 1.2-5.0). Age 80+ (odds ratio (OR) 1.6, 
1.3-1.9), female sex (OR 2.2, 1.4-3.4) and BMI ≤18.5 (OR 3.5, 1.2-10.1) were significant 
risks for dementia in Nigeria. Using our epidemiologic model, we estimated that the 
number of dementia cases increased by over 400% over a 20-year period, increasing 
from 63 512 in 1995 to 318 011 in 2015 among persons aged ≥60 years.
Conclusion: Our findings suggest the prevalence and cases of dementia have in-
creased in Nigeria over the last two decades. Population-wide response to demen-
tia is lacking.
Dementia is a clinical syndrome caused by neurodegeneration and character-
ized by progressive deterioration in cognition and capacity for independent 
living (1). It has been described as a global epidemic (2). The occurrence of de-
mentia in low- and middle-income countries (LMICs) is closely linked to pop-
ulation ageing and thus may continue to rise for decades (2, 3). Globally, about 
47.5 million people are living with dementia, with over two-thirds residing in 
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LMICs, including Africa, where there is very limited access to social protection, and relevant 
care, services and support (1).
Documented country-specific dementia prevalence in sub-Saharan Africa (sSA) ranges be-
tween 2% and 5% (4, 5). Although in most of these settings, dementia research is relatively 
poor; consequently, the awareness and response to dementia have been limited (6). In Nige-
ria, several communities still link dementia to a normal process of ageing, with many pa-
tients stigmatised and abandoned in the belief that their condition is beyond any medical 
intervention (7). Thus, many of those affected delay seeking medical care and endure poor 
outcomes (8). This is exacerbated by poor mental health service access which partly results 
in high out-of-pocket expenses that few can afford (9, 10).
The Ibadan study of ageing group (10-12), covering several parts of the south-west Nigeria, 
is widely recognized as a leading research group on dementia in Nigeria. The group over 
the last two decades, has contributed to the understanding of the burden of dementia in the 
south-west region. However, the remaining five of the six geopolitical zones in the country 
lack recent epidemiologic data. Population-based research studies on dementia have been 
sparsely conducted in Nigeria (6), a view already reported by the 10/66 dementia research 
group for several LMICs (13). Prince and colleagues (6), however, called for increased efforts 
towards gathering available research evidence on the burden of dementia to further raise 
awareness on the numbers of people affected and inform relevant policy interventions. We 
therefore systematically reviewed available evidence on dementia in Nigeria to provide esti-
mates of the prevalence and risks of dementia that can subsequently prompt a much-needed 
policy response and country-wide public health interventions.
METHODS
Search strategy
We searched relevant databases, including MEDLINE, EMBASE, Global Health 
(CABI), and Africa Journals Online (AJOL), for epidemiologic studies on de-
mentia in Nigeria. Search terms are shown in Table 1. Searches were conduct-
ed on 31 July 2018 and limited to studies published after 1 January 1990. Un-
published documents were sourced from Google Scholar and Google searches. 
Titles and abstracts of studies were reviewed, and full-texts of relevant studies 
accessed. The reference lists of accessed full-texts were further hand-searched 
for additional studies. The authors of selected papers were contacted for miss-
ing information.
Selection criteria
We primarily selected population-based studies reporting on the prevalence or 
risks of dementia in a Nigerian setting. However, due to high number of hospi-
tal-based studies we identified from an initial scoping exercise reporting risks 
of dementia, we also carefully reviewed and selected hospital-based studies if 
they clearly defined the reference population of the hospital (which we ascer-
tained by checking with the authors or relevant authorities of the hospital). We 
excluded any other hospital-based studies with poor or no description of refer-
ence population. Other studies excluded include studies on Nigerians in diaspo-
ra, reviews, case-reports, view-points and commentaries.
Data extraction
Assessment of eligible studies was conducted independently by two reviewers (DA and AA), 
with an eligibility guideline to ensure that selection consistent criteria were applied. Any 
disagreement in study selection was resolved by consensus. Data on the location, study pe-
riod, study design, study setting (urban or rural), sample size, diagnostic criteria and mean 
Table 1. Search terms
# SEARCHES
1
africa/ or africa, sub-sahara/ or africa, 
western/ or nigeria/
2 exp vital statistics/
3
(incidence* or prevalence* or morbidity 
or mortality).tw.
4 (disease adj3 burden).tw.
5 exp "cost of illness"/
6 case fatality rate.tw
7 hospital admissions.tw
8 Disability adjusted life years.mp.
9 (initial adj2 burden).tw.
10 exp risk factors/
11 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
12
exp dementia/ or exp alzheimer’s dis-
ease/ or exp cognitive impairment/ or 
exp parkinson’s disease/
13 1 and 11 and 12
14 Limit 13 to “1990-current”
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age of the population were extracted. These were matched with corresponding data on de-
mentia cases, sample population, prevalence, and estimated risks of dementia in each study. 
For studies conducted on the same study site, population or cohort, the first published study 
was selected, and all additional data from the other studies were extracted and merged with 
data from the selected paper.
Quality assessment
For the quality assessment, we adapted the Alzheimer’s Disease International study selection 
and quality criteria (1). For each full text selected, we screened for adherence to protocol in 
the study design (was there a protocol?), sampling method (was it representative of a target 
subnational population?), and case ascertainment (was it based on standard diagnostic cri-
teria, measurement of cognitive impairment or unspecified clinical criteria, informant inter-
views, or not reported?). Studies were graded as high (4, 5), moderate (2, 3), or low quality (0-
1) (see Tables 2 and 3, for details of all full-text manuscripts accessed and quality grading).
Table 2. Quality assessment of selected studies
QUALITY CRITERIA ASSESSMENT SCORE MAXIMUM 
SCORE
Protocol (was there a protocol?) Yes 1
1
No 0
Sampling method (was it representative of a target subnational pop-
ulation?)
Yes 1
1
No 0
Case ascertainment (was it based on standard diagnostic criteria or 
measurement of cognitive impairment, other clinical criteria, infor-
mant interviews, or not reported?)
Standard diagnostic criteria 3
3
Measurement of cognition or other 
clinical criteria
2
Informant interviews 1
Not-reported 0
Total (high (4, 5), moderate (2, 3), or low quality (0-1)) 5
Table 3. Characteristics of selected studies
AUTHOR. YEAR STUDY DESIGN CASE ASCERTAIN-
MENT
LOCATION GEO-POLITICAL 
ZONE
SETTING MEAN AGE 
(YEARS)
PREVALENCE 
%
QUALITY 
GRADING
Adebayo et al. 
2016 (18)
2007-2011 Hospital-based survey ICD-10, Clinical 
criteria
Lagos South-west Urban 69.6 4.60 Medium
Gureje et al. 2006 
(19)
2003-2004 Community-based 
household survey
10-WDRT Ibadan South-west Peri-urban 74.4 10.10 Medium
Gureje et al. 2011 
(20)
2007 Community-based 
household survey 
(two-phase study)
C-SID Ibadan South-west Peri-urban 74.5 6.94 High
Hendrie et al. 1995 
(10, 21)
1992-1993 Community-based 
household survey 
(two-phase study)
DSM-III-R and 
ICD-10
Ibadan South-west Peri-urban 81 2.29 High
Hendrie et al. 2001 
(22)
1997-1998 Community-based 
household survey 
(two-phase study)
DSM-III-R, ICD-10 Ibadan South-west Peri-urban 74.2 1.14 High
Ochayi & Thatcher 
2006 (23)
2002 Community-based 
household survey
Standardized 
CSI-D
Jos North-central Peri-urban 73 6.40 Medium
Ogunniyi et al. 
2016 (24)
2013 Community-based 
cross-sectional study
DSM-IV, 
NINCDS-ADRDA, 
Peterson's criteria
Lalupon South-west Rural 70 2.80 High
Yusuf et al. 2011 
(25)
2011 Community-based 
household survey
CSI-D, CERAD, 
SDT, BDS
Zaria North-west Urban 75.5 2.80 Medium
Yusuf et al. 2018 
(26)
2017 Hospital-based 
survey
CSI-D, CERAD, 
SDT, BDS
Zaria North-west Urban 75 8.24 Medium
Note: 10-WDRT: 10-Word Delayed Recall Test, BDS: Blessed Dementia Scale, CSI-D: Community Screening Instrument for Dementia, CERAD: Consortium to Es-
tablish a Registry for Alzheimer’s Disease; DSM: Diagnostic and Statistical Manual of Mental Disorders; ICD: International Classification of Diseases, NINCDS-
ADRDA: National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association, SDT: Stick 
Design Test
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Data analysis
A random effects meta-analysis, using the DerSimonian and Laird Method (14), was employed 
on the individual study estimates to generate national and sub-national summary estimates 
of prevalence and risk of dementia in Nigeria. Standard errors were determined from the 
reported crude estimates and population denominators, assuming a binominal (or Poisson) 
distribution. Heterogeneity between studies was assessed using I-squared (I2) statistics, and 
subgroup analysis was conducted to detect causes of heterogeneity. A meta-regression epi-
demiologic model based on aggregated age from each study (as this was statistically signif-
icant) was applied to extracted prevalence rates. The model accounted for study sample size, 
study period, and estimated sex-based risk (for sex distribution). We employed the model to 
estimate the absolute number of cases of dementia at midpoints of the United Nation (UN) 
population 5-year age groups for Nigeria for the years 1995 and 2015 (15). Our approach to 
data analysis has been described in detail in previous studies (16, 17). All statistical analyses 
were conducted on STATA (Stata Corp V.14, Texas, USA). The study was conducted in strict 
compliance to the PRISMA guidelines.
RESULTS
Search results
Our searches returned 835 studies (MED-
LINE 278, EMBASE 491, Global Health 
58, and AJOL 8). Additional three studies 
were identified through Google Scholar, 
websites and reference lists of relevant 
studies. After duplicates have been re-
moved, 440 titles were screened for rel-
evance. On applying the selection cri-
teria, 396 studies were excluded. Of the 
remaining 44 full-texts assessed, nine 
studies (18-26) were finally selected for 
the review (Figure 1).
Study Characteristics
Nine studies (7 population-based and 2 
hospital-based) spread across the south-
ern and northern parts of Nigeria were 
selected (Table 2). Specifically, six stud-
ies were retained from the South-west, 
two from the North-west and one from 
the North-central. Five studies were con-
ducted in peri-urban settings, which we 
define as a mix of urban and rural dwellers. Four studies were rated as high quality, with 
the remaining five rated as moderate quality. Study period ranged from 1992 to 2017, with 
four studies (44.4%) conducted after 2010. The total population included in the review was 
10,820, with a median age of 74.4 years (Table 3).
Estimated prevalence of dementia in Nigeria
There were 43 data-points on the prevalence of dementia in Nigeria, 31 on dementia, five on 
Alzheimer’s disease, three on mixed dementia and two each on vascular dementia and Par-
kinson’s disease (see Online Supplementary Document for all data points on prevalence). 
Heterogeneity was high across studies, with I-squared (I2) estimated at 98.8% (P<0.001). From 
all data points, the pooled crude prevalence of dementia in Nigeria was 4.9% (95% CI: 3.0-6.9) 
Figure 1. Flow chart of selection of dementia studies in Nigeria.
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(Figure 2), with prevalence in women (6.7%, 3.6-9.9) significantly higher than in men (3.1%, 
1.2-5.0), P<0.05 (Figures 3 and 4). The prevalence was highest in North-central (6.4%, 3.5-
9.3), followed by North-west (5.4%, 0.1-10.7) and South-west (4.6%, 2.3-6.9). Prevalence was 
also higher in urban settings (4.9%, 2.5-7.4) compared to rural settings (2.8%, 1.5-4.1). As al-
ready reported as a disease associated with ageing, we observed an increasing prevalence with 
advancing age of the population, with prevalence consistently increasing from 3.9% (2.1-5.7) 
among persons aged 60-69 years to 11.0% (6.7-15.3) among persons aged 90 years or more 
(Table 4). Of the dementia subtypes, Alzheimer’s disease had the highest prevalence at 2.0% 
(1.0-2.9). Other dementia subtypes had prevalence rates less of than 1% (Figure 5, Table 4).
Estimated risk of dementia in Nigeria
We extracted data on 16 different risk factors yielding a total of 55 data points from all stud-
ies (see Online Supplementary Document for all data points on risks). Of all extracted risk 
factors, age, female sex and BMI were significant determinants for dementia in Nigeria. At 
80 years or more, the risk of dementia increased by almost 60% (odds ratio (OR) 1.58, 95% CI: 
1.32-1.88). There was about 120% increased risk of dementia in the female sex (OR 2.18, 95% 
CI: 1.41-3.36), which is in keeping with our estimated prevalence rate distribution in the two 
Figure 3. Pooled prevalence rate of dementia in Nigeria, Men.
Figure 2. Pooled prevalence rate of dementia in Nigeria, Both sexes.
Figure 4. Pooled prevalence rate of dementia in Nigeria, Women.
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sexes (male 3.1%, female 6.7%). Body mass index (BMI) 18.5 or less was also a leading risk of 
dementia observed in this study (OR 3.50, 95% CI: 1.22-10.05). Although, other contributing 
risks of dementia in a Nigerian population included being a widow (OR 1.47, 0.9-2.3), having 
no education (OR 2.36, 1.0-5.6), low socio-economic status (OR 1.52, 0.8-2.9), rural residence 
(OR 1.45, 0.8-2.9), history of alcohol (OR 1.51, 1.0-2.3), and history of stroke (OR 1.37, 0.7-2.5), 
they were however not statistically significant (Figure 6).
Estimated number of dementia cases in Nigeria
The meta-regression epidemiologic modelling, adjusted for study period (1992-2017) and 
sample size (total 10 820), was applied to mean ages and crude prevalence rates of dementia 
extracted from all studies. As noted in the prevalence estimates, the modelling revealed an 
increasing prevalence with age (P<0.05) (see Online Supplementary Document for meta-re-
gression model). Using the United Nations demographic projections for Nigeria and incorpo-
Table 4. Pooled crude estimates of dementia prevalence in Nigeria
SUBGROUP DATA BOTH SEXES (95% CI) I2, P VALUE DATA POINTS
Dementia types
Dementia
All 4.9 (3.0-6.9) 98.8, <0.001 9
Male 6.7 (3.6-9.9) 95.9, <0.001 8
Female 3.1 (1.2-5.0) 92.0, <0.001 8
Alzheimer’s disease 2.0 (1.0-2.9) 80.0, <0.001 5
Mixed dementias 0.8 (0.2-1.4) 56.1, 0.102 3
Vascular dementias 0.3 (0.1-0.5) 0.0, 0.969 3
Parkinson’s disease 0.1 (0.03-0.3) 34.3, 0.217 2
Geopolitical zone
North-central 6.4 (3.5-9.3) - 1
North-west 5.4 (0.1-10.7) 89.6, <0.001 2
South-west 4.6 (2.3-6.9) 97.8, <0.001 6
Setting
Rural 2.8 (1.5-4.1) - 1
Urban 4.9 (2.5-7.4) 79.4, <0.001 3
Peri-urban (mixed urban-rural) 5.3 (2.4-8.2) 98.2, <0.001 5
Age
60-69 3.9 (2.1-5.7) 93.1, <0.001 7
70-79 6.3 (4.1-8.5) 95.7, <0.001 14
80-89 10.1 (1.2-19.1) 97.2, <0.001 5
90+ 11.0 (6.7-15.3) 18.1, 0.299 5
Figure 5. Pooled prevalence of dementia subtypes in Nigeria.
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rating the significant female risk of dementia (to determine sex distribution), we estimated 
63 527 dementia cases in 1995 among person aged 60 years or more. Driven partly by the 
rapid demographic changes observed in Nigeria, this increased significantly to 318 011 de-
mentia cases in 2015. This increase accounts for over 400% increase in the absolute number 
of dementia cases among persons aged 60 years or more over the 20-year period (Table 5).
DISCUSSION
Nigeria has one of the most rapid demographic transitions in Africa. A population health 
consequence of the associated population ageing is dementia. According to the UN estimates 
(15), the population of Nigerians aged ≥60 years nearly doubled from approximately 5 million 
in 1995 to 9.5 million in 2015. Thus, even if the existing age- and sex-specific prevalence of 
dementia remains stable, there will be an increase in the number of older individuals at risk 
of progressing into dementia (1, 2).
With dementia cases estimated at about 64 000 in Nigeria in 1995, it is compelling to suggest 
that the burden of dementia may have been previously low and gradually increasing in the 
Figure 6. Risk factors for dementia in Nigeria, pooled odds ratio. Note: BMI: body mass index, Hx: history, 
SES: socio-economic status.
Table 5. Absolute number of cases of dementia in Nigeria among persons aged 60 years or more, 1995 and 
2015
AGE 1995 2015
All Men Women All Men Women
60-64 188 59 129 31295 9841 21454
65-69 865 272 593 70394 22136 48257
70-74 19305 6071 13234 83262 26183 57079
75-79 21436 6741 14695 68816 21640 47176
80-84 14009 4405 9604 41584 13077 28507
85-89 5878 1848 4030 17250 5424 11825
90+ 1835 577 1258 5411 1702 3709
Total 60+ 63517 19974 43543 318011 100004 218008
Note: Estimates based on the epidemiologic modelling from all datapoints.
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country over the last two to three decades. In a 1992 study in Ibadan, South-west Nigeria, 
Ogunniyi et al. (27) identified no cases of dementia in their study, reporting that the disease 
was relatively rare in Nigeria. Further studies in the same location (21, 22, 28) gradually 
identified dementia cases, with the most surprising being a prevalence of 10.1% in 2006 (19).
We estimated an overall dementia prevalence of 5% (3.0-6.9) in Nigeria. To the best of our 
knowledge, this is the first national prevalence of dementia in the country based on a syn-
thesis of diverse publicly available evidence. Our prevalence estimate is similar to that for 
Africa in the World Alzheimer Report for 2013 (4.6%) and 2015 (5.5%) (1, 29). However, Mav-
rodaris et al (4) reported that prevalence rates of dementia in sSA ranged from 0% to 10.1%, 
and George-carey et al (5) estimated a dementia prevalence of 2.4% in sSA in 2012, which 
are both not in congruent with our current estimate. As these are aggregated estimates from 
different African countries where relatively little dementia research effort occurs, it is un-
derstandable that dementia prevalence may vary widely between, and even within, differ-
ent countries (6).
For example, genetic, cultural, and nutritional variation across the continent, and within 
African countries may have impacted the natural history of chronic disease prevalence, in-
cluding dementia (6). This may be reflected in the different prevalence rates reported. Other 
factors that may have affected estimation include methodological issues, case definitions, 
validity and reliability of screening instruments, and under-reporting from routine medical 
records (5, 8, 13). In contrast, Prince and colleagues (2) suggested that the actual prevalence 
of dementia only varies slightly between world regions, reporting a narrow range of 5-7% 
across countries, which appears to be in keeping with the World Alzheimer Report estimates 
for Africa and our current estimate for Nigeria.
We also estimated prevalence rates for dementia subtypes in Nigeria, with Alzheimer’s dis-
ease being the most prevalent at 2% (1.0-2.9). Alzheimer’s disease is the most common type 
of dementia globally and poses a substantial burden to patients, caregivers, and the health 
system (1). In sSA, George-carey et al (5) estimated that Alzheimer’s disease accounted for al-
most 60% of dementia cases in the region in 2012. However, interpreting reported prevalence 
rates of dementia subtypes in Africa may need to be undertaken cautiously. First, due to ap-
parent overlaps in the case definitions of dementia subtypes, particularly dementia, Alzhei-
mer’s disease and vascular dementia, misclassification bias may have been a problem during 
case ascertainment (5). Second, dementia research is still evolving in Africa, with a relative-
ly higher likelihood of errors from survey designs and use of screening instruments (4, 8).
Advancing age is the single most important risk of developing dementia, which was par-
ticularly significant for persons aged 80 years or more in this study. Although a decline in 
age-related incidence may be plausible with substantial reduction in exposures to other risks 
including environmental, lifestyle and cardiovascular risks (30, 31). The increased risk of 
dementia in women observed in this study (from prevalence estimates and risk estimation) 
has also been reported previously (31). As women tend to live longer than men, they endure 
a survivor burden owing to higher prevalence of some diseases, such as dementia, especial-
ly when they have co-existing cardiovascular conditions (13). However, one important link 
is the presence of apolipoprotein E gene (APOE4 allele), a known risk of early-onset demen-
tia, which creates proteins that transport fatty substances in the blood stream. Altman and 
colleagues (32) found that women who carry a copy of APOE4 allele were twice as likely to 
develop Alzheimer’s disease, while men with the gene had only slightly increased risk, sug-
gesting that APOE4 allele confers more risk of dementia in women compared to men. The 
link between dementia and BMI is controversial, hence our estimate of increased risk with 
BMI≤18.5 requires further research. Some studies have examined the association between 
weight and dementia, reporting that the risk of dementia increased among those overweight 
or obese (6, 33). However, in a UK retrospective cohort study of about 2 million people over 
two decades, the authors reported that underweight people had a 34% increased risk of de-
mentia compared to normal weight individuals and that the incidence of dementia consis-
tently dropped with rise in BMI (34). While the contexts of these studies are obviously dif-
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ferent from Nigeria, the contradicting reports further affirms a need for more research on 
BMI and dementia.
Although the Ibadan group have pioneered dementia research in Nigeria, it has been iso-
lated mainly to South-west Nigeria. Further, few studies have addressed modifiable risks of 
dementia in the population, thus limiting population-wide guidance for the promotion of 
preventive measures (6). The lack of comprehensive care and support institutions for people 
living with dementia is another setback in Nigeria (35). Care for dementia is largely provid-
ed by family members and occasionally community care-givers. While better than no sup-
port, both groups suffer from a poor understanding of the disease and are burdened from 
the stress of providing care and the diverse behavioural disturbances of their loved ones. A 
bill to pass the Nigerian Mental Act, believed to potentially drive an improved response to 
dementia, was only re-introduced in 2013, having been withdrawn from the National As-
sembly for nearly five years due to unresolved political issues (7). The bill however broadly 
focused on protecting the rights of individuals with mental disorders and setting standards 
for mental health practice in the country. It is therefore important for policymakers to direct 
efforts at ensuring adequate infrastructure, personnel, training and research that focus on 
dementia, among other important mental health needs, in Nigeria.
This study has limitations. First, there were no studies specifically from the South-east, 
South-south and North-east of Nigeria that met our selection criteria. Second, study hetero-
geneity was high due to variation in study designs, case definitions, and individual popula-
tion characteristics. The selection of two hospital-based studies could have also contributed 
to this heterogeneity; we however ensured these were properly screened and reference pop-
ulation clearly defined. Third, there were only four studies assessed as high quality, which 
obviously has implications on the interpretation of our results. Notwithstanding, the data 
and estimates provided in this study have been derived from the best available evidence on 
dementia in Nigeria and may contribute to better awareness and response to the disease in 
the country.
CONCLUSION
The prevalence and cases of dementia is increasing in Nigeria, driven mostly by rapid popu-
lation ageing. There are still very few rigorous population-based studies on dementia prev-
alence and risk, and this apparently sustains a poor understanding of the diseases across 
many Nigerian settings. While there is need for the government and policy makers to ad-
dress this issue more keenly, the country may also benefit from international collaborations 
towards advancing dementia research and overall mental health services in the country. It 
is hoped that the findings of this study may prompt a much-needed policy and public health 
response to dementia across Nigeria.
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